In-vitro Susceptibility of Cryptococcus Neoformans and Candida Species to Five Antifungal Drugs

苏逸丹,汪师贞,翁心华,章强强

2000-01-01

Abstract:Objective To mudy the in-vitro susceptibilities of Cryptococcus,neooformans and Candida species collected from clinical samples(cerebrospinal fluid,sputum,urine and stool)to fluconazole,amphotericin B,itraconazole,5-flucytosine and ketoconszoh.The consistence of susceptibilities and clinical treatrnent efficacy was also evaluated.Methods 35 isolates of Cryptococcus neoformans and 56 isolates of Candida species were tested for their susceptibilities to five antifungal agents by broth microdilution method according to the Nationa Committee of Clinical Laboratory Standard Recommendations(document M27A).Results The susceptibilities of 56 isolates of Candida species to five antifungal agents were hsted as follows:fluconazole 0.125～64μg/ml,94.6%of them were susceptible,1.8%were dose-dependeny susceptible,3.6%were resistant;itraconazole 0.03～1 μg/ml,57.1%were susceptible,37.5%were dosedependent susceptible,5.4%were resistant;5-flucytosine 0.125～32μg/ml,92.8%were Susceptible,3.6%were intemediate sensitire,3.6%were resistant;amphotericin B 0.06～2 μg/ml,ketoconazole 0.03～0.5μ/ml.The MIC ranges of 35 isolates of Cryptococcus neoformans were:fluconazole 2～64 μg/ml,itraconazole 0.25～1 μg/ml,amphotericin B 0.03～1 μg/ml,5-flucytosine 0.25～64 μg/ml,ketoconazole 0.125～1 μg/ml.Conclusions The MICs of five antifungal drugs for Cryptococcus neoformans and Candida species obtained by the NCCLS M27-A method were consistent and could be reproduced.